United Therapeutics (UTHR) volatility Flat into Phase three results
Tweet Send to a Friend
United Therapeutics (Nasdaq: UTHR) : UTHR closed at $91.09. Phase three data from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
